URGENT.LY INC (ULY) Fundamental Analysis & Valuation

NASDAQ:ULY • US9169312074

2 USD
-0.07 (-3.38%)
Last: Mar 10, 2026, 03:42 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ULY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Overall ULY gets a fundamental rating of 1 out of 10. We evaluated ULY against 277 industry peers in the Software industry. ULY may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ULY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. ULY Profitability Analysis

1.1 Basic Checks

  • In the past year ULY has reported negative net income.
  • In the past year ULY has reported a negative cash flow from operations.
  • ULY had negative earnings in 4 of the past 5 years.
  • ULY had a negative operating cash flow in each of the past 5 years.
ULY Yearly Net Income VS EBIT VS OCF VS FCFULY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • ULY has a Return On Assets of -58.49%. This is amonst the worse of the industry: ULY underperforms 86.28% of its industry peers.
Industry RankSector Rank
ROA -58.49%
ROE N/A
ROIC N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ULY Yearly ROA, ROE, ROICULY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

  • ULY's Gross Margin of 24.35% is on the low side compared to the rest of the industry. ULY is outperformed by 80.51% of its industry peers.
  • ULY's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ULY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
ULY Yearly Profit, Operating, Gross MarginsULY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ULY Health Analysis

2.1 Basic Checks

  • ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ULY has less shares outstanding
  • ULY has less shares outstanding than it did 5 years ago.
  • ULY has a worse debt/assets ratio than last year.
ULY Yearly Shares OutstandingULY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ULY Yearly Total Debt VS Total AssetsULY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • ULY has an Altman-Z score of -6.51. This is a bad value and indicates that ULY is not financially healthy and even has some risk of bankruptcy.
  • ULY has a Altman-Z score of -6.51. This is amonst the worse of the industry: ULY underperforms 85.20% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.51
ROIC/WACCN/A
WACC9.63%
ULY Yearly LT Debt VS Equity VS FCFULY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • ULY has a Current Ratio of 0.34. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ULY's Current ratio of 0.34 is on the low side compared to the rest of the industry. ULY is outperformed by 94.58% of its industry peers.
  • ULY has a Quick Ratio of 0.34. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.34, ULY is doing worse than 94.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
ULY Yearly Current Assets VS Current LiabilitesULY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ULY Growth Analysis

3.1 Past

  • ULY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.80%.
  • Looking at the last year, ULY shows a very negative growth in Revenue. The Revenue has decreased by -17.95% in the last year.
  • ULY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 305.71% yearly.
EPS 1Y (TTM)-142.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.71%
Revenue 1Y (TTM)-17.95%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-9.11%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.74% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ULY will show a small growth in Revenue. The Revenue will grow by 7.45% on average per year.
EPS Next Y56.28%
EPS Next 2Y37.29%
EPS Next 3Y26.97%
EPS Next 5Y21.74%
Revenue Next Year-10.26%
Revenue Next 2Y3.32%
Revenue Next 3Y7.45%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ULY Yearly Revenue VS EstimatesULY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ULY Yearly EPS VS EstimatesULY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. ULY Valuation Analysis

4.1 Price/Earnings Ratio

  • ULY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ULY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ULY Price Earnings VS Forward Price EarningsULY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ULY Per share dataULY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ULY's earnings are expected to grow with 26.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.29%
EPS Next 3Y26.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ULY Dividend Analysis

5.1 Amount

  • No dividends for ULY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ULY Fundamentals: All Metrics, Ratios and Statistics

URGENT.LY INC

NASDAQ:ULY (3/10/2026, 3:42:08 PM)

2

-0.07 (-3.38%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12
Earnings (Next)03-10
Inst Owners5.94%
Inst Owner Change-20.69%
Ins Owners3.46%
Ins Owner Change-0.22%
Market Cap4.38M
Revenue(TTM)127.93M
Net Income(TTM)-25.00M
Analysts80
Price Target11.73 (486.5%)
Short Float %8.33%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.54%
Min EPS beat(2)-65.02%
Max EPS beat(2)-50.07%
EPS beat(4)0
Avg EPS beat(4)-75.68%
Min EPS beat(4)-121.92%
Max EPS beat(4)-50.07%
EPS beat(8)2
Avg EPS beat(8)46.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.98%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-0.44%
Max Revenue beat(4)1.2%
Revenue beat(8)4
Avg Revenue beat(8)1.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.75
EYN/A
EPS(NY)-4.19
Fwd EYN/A
FCF(TTM)-5.9
FCFYN/A
OCF(TTM)-3.47
OCFYN/A
SpS58.42
BVpS-20.64
TBVpS-25.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -58.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.35%
FCFM N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
F-Score4
Asset Turnover2.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 127.92%
Cap/Sales 4.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -6.51
F-Score4
WACC9.63%
ROIC/WACCN/A
Cap/Depr(3y)63.32%
Cap/Depr(5y)101.16%
Cap/Sales(3y)2.81%
Cap/Sales(5y)25.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-142.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.71%
EPS Next Y56.28%
EPS Next 2Y37.29%
EPS Next 3Y26.97%
EPS Next 5Y21.74%
Revenue 1Y (TTM)-17.95%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-9.11%
Revenue Next Year-10.26%
Revenue Next 2Y3.32%
Revenue Next 3Y7.45%
Revenue Next 5YN/A
EBIT growth 1Y76.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.34%
EBIT Next 3Y34.58%
EBIT Next 5YN/A
FCF growth 1Y12.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.42%
OCF growth 3YN/A
OCF growth 5YN/A

URGENT.LY INC / ULY FAQ

Can you provide the ChartMill fundamental rating for URGENT.LY INC?

ChartMill assigns a fundamental rating of 1 / 10 to ULY.


What is the valuation status for ULY stock?

ChartMill assigns a valuation rating of 1 / 10 to URGENT.LY INC (ULY). This can be considered as Overvalued.


How profitable is URGENT.LY INC (ULY) stock?

URGENT.LY INC (ULY) has a profitability rating of 0 / 10.


How financially healthy is URGENT.LY INC?

The financial health rating of URGENT.LY INC (ULY) is 1 / 10.